NOVT Novanta Inc
Company Analysis
Latest News
🟢 Novanta is trading 13% up today after Q2 beat and raised 2026 guidance
Novanta is trading 12.91% up now at $172.89 after August 5, 2026, second-quarter results beat expectations. - Adjusted EPS was $0.89 versus $0.83 expected;...
🟢 Novanta is trading 5.9% up today after Q2 earnings beat and raised guidance
Novanta is trading 5.9% up now at $166.54 after its August 5 earnings release beat expectations. - Q2 revenue was $265.8 million, with adjusted EPS of...
🟢 Novanta is trading 4.49% up in pre-market after strong Q2 earnings and raised 2026 guidance
Novanta is trading 4.49% up at $160.00 after second-quarter results beat expectations. - Revenue reached $265.8 million, while adjusted EPS was $0.89 versus...
Novanta's second quarter revenue of $266M and EPS of $0.89 beat estimates, driven by strong 9.3% organic growth.
Novanta reported second quarter 2026 revenue of $265.8 million, up 10.3% year-over-year, with adjusted EPS increasing 17.1% to $0.89. Both figures surpassed...
🟢 Novanta is trading 5.6% up today ahead of Q2 earnings and amid a broader industrials rally
Novanta is trading 5.6% up at $156.29 as investors position ahead of its second-quarter 2026 earnings release scheduled for August 5, with consensus expecting...
Novanta Inc Q2 2026 Earnings Preview: What Analysts Expect on August 05, 2026
For the second quarter of 2026, consensus estimates place Novanta’s revenue at $262.1 million and adjusted EPS at $0.83, with the current stock price of...
🟢 Novanta is trading 4.05% up today amid a broader tech-led risk-on rally
Novanta is trading at $148.32 (up 4.05%), moving in line with a strong risk-on tone across U.S. equities. • Major indices are trending higher, led by a 2%...
🟢 Novanta is trading 4.1% up today amid broader risk-on sentiment and tech gains
Novanta is trading at $144.58 (+4.08%) today, with the move appearing to be driven by a broader risk-on tone in the market rather than company-specific...
Novanta Completes $1.45 Billion Acquisition of Medical Device Firm Riverpoint Medical
Novanta Inc. (NOVT) announced it has completed the acquisition of Riverpoint Medical, a manufacturer of minimally invasive surgical consumables. The...
🟢 Novanta is trading 9.8% up today on broader risk-on sentiment
Novanta is trading 9.8% up at $155.40 today on broader risk-on sentiment, as the stock tracks a wider market rally despite a lack of company-specific news. •...
🔴 Novanta is trading 4.1% down today as investors pull back from high-valuation tech
Novanta is trading 4.1% down today at $150.30 as investors pull back from high-valuation technology names in a broader risk-off move. • The decline follows a...
🟢 Novanta is trading 4.8% up today after analyst upgrades and conviction list addition
Novanta is trading at $164.23 (+4.84%) in after-hours trading following a rebound driven by significantly improved analyst sentiment. • William Blair added...
🟢 Novanta is trading 4% up today as analyst upgrades and conviction list addition fuel rebound
Novanta is trading 4% up at $157.73 as shares extend a recovery from the sharp sell-off on July 7. • William Blair recently added the company to its July...
🟢 Novanta is trading 4.1% up today on analyst conviction list inclusion and Zacks upgrade
Novanta is trading 4.1% up today at $154.62 as the stock rebounds from a recent sell-off following multiple positive analyst actions. • William Blair added...
🟢 NOVT Jumps 5.5% as William Blair Adds to Conviction List, Zacks Upgrades
• NOVT is trading at $155.94, up 5.5%, attempting a partial recovery from Tuesday's 10.33% sell-off on July 7, 2026. • The stock is boosted by William Blair...
🔴 NOVT makes sharp 10.5% drop
NOVT is trading at $147.62, down 10.5% versus the comparison close of $164.89 during regular trading. This is a price-movement alert; no separate...
🔴 Novanta Inc is trading 6.02% down
NOVT is trading at $154.97, down 6.02%.
🟢 NOVT is trading 9.2% up today after analyst lifts fair value on accelerating Q1 bookings
NOVT is trading at $180.00 (9.2% up) in pre-market after analyst commentary highlighted accelerating Q1 bookings and raised the stock’s fair value estimate to...
Novanta Surges to $175 Fair Value After Blockbuster Bookings — But Can a $1.45 Billion Bet on Surgery Keep the Momentum Alive?
Shares of Novanta jumped 7.6% in pre-market trading to $173.94, closing a gap that had persisted since analysts raised their fair value estimate from $171.50...
🟢 NOVT is trading 7.6% up today after analysts raise fair value on stronger earnings power
NOVT is trading 7.6% up at $173.94 following positive analyst commentary and an increased fair value estimate toward $175 per share. • Analysts updated models...